Personalis, Inc.
NASDAQ: PSNL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Christopher Hall
- Employees
- 228
- Headquarters
- Fremont, United States
- IPO year
- 2019
- Market cap
- $1.0B
- Website
- https://www.personalis.com
Loading PSNL…
Loading profile data…Frequently asked questions about PSNL
What does Personalis, Inc. (PSNL) do?
Personalis, Inc. operates globally as a specialized cancer genomics firm. The company delivers advanced sequencing and data analysis capabilities, primarily supporting the development of novel cancer treatments and facilitating extensive genetic research initiatives. Central to their offerings is the NeXT Platform, which enables detailed data an...
Where does PSNL trade?
Personalis, Inc. (PSNL) trades on the NASDAQ Global Market.
What sector is PSNL in?
Personalis, Inc. (PSNL) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Personalis, Inc.?
Christopher Hall is the chief executive officer of Personalis, Inc. (PSNL).
Where is Personalis, Inc. headquartered?
Personalis, Inc. is headquartered in United States.
Does PSNL pay a dividend?
Personalis, Inc. (PSNL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PSNL go public?
Personalis, Inc. (PSNL) completed its initial public offering in 2019.